ABX
Abacus Global Management, Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Gross AUM | $3.6B | Q1 2026 | — |
| Gross capital inflows | $378M | Q1 2026 | — |
| Longevity Income Funds AUM | $1B | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | 132.6M | full year 2025 | — |
| Number of policy originations | 1,310 | full year 2025 | — |
| Origination capital deployment | 230.7M | the fourth quarter of 2025 | — |
| Originations capital deployment | 580.8M | full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABX
this stock
Abacus Global Management, Inc.
|
$1.14B | +38.7% | +68.6% | 31.2 | 6.2% |
|
CILJF
China Life Insurance Co Ltd
|
$100.34B | +2.9% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$68.59B | +14.6% | — | — | 0.8% |
|
AFL
Aflac Inc
|
$61.53B | +10.2% | -9.3% | 13.8 | 2.1% |
|
MET
Metlife Inc
|
$57.95B | +14.9% | +8.6% | 17.4 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABX | +28.4% | +42.9% | +36.0% | +10.7% | +38.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +26.9% | +44.1% | +28.0% | +11.0% | +29.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.